Back

Cytokinetics Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Buy

CYTK
Cytokinetics

Last Price:

67.47

Seasonality Move:

12.39%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.

Cytokinetics Price Quote

$67.47

-0.08 (0.7%)

(Updated: April 20, 2024 at 6:11 AM ET)

Cytokinetics Key Stats

Buy

Cytokinetics (CYTK) is a Buy

Day range:

$64.82 - $67.80

52-week range:

$25.98 - $110.25

Dividend yield:

P/E ratio:

0.00

P/S ratio:

865.88

P/B ratio:

Volume:

1.4M

Avg. volume:

2.2M

1-year change:

78.09%

Market cap:

$7B

Revenue:

$7.5M

EPS:

$-5.45

How Much Does Cytokinetics Make?

How Much Are Cytokinetics's Sales Annually?
CYTK Revenues are $7.5M
How Much Profit Does Cytokinetics's Make A Year?
CYTK net income is -$526.2M

Is Cytokinetics Growing As A Company?

What Is Cytokinetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.15%
What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Cytokinetics Stock Price Performance

Did Cytokinetics Stock Go Up Last Month?
Cytokinetics share price went down by -0.06% last month
Did CYTK's Share Price Rise Over The Last Year?
CYTK share price rose by 78.09% over the past 1 year

What Is Cytokinetics 52-Week High & Low?

What Is Cytokinetics’s 52-Week High Share Price?
Cytokinetics has traded as high as $110.25 over the past 52 weeks
What Is Cytokinetics’s 52-Week Low Share Price?
Cytokinetics has traded as low as $25.98 over the past 52 weeks

Cytokinetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cytokinetics?

How Much Debt Does Cytokinetics Have?
Total long term debt quarterly is $617.5M
How Much Cash Does Cytokinetics Have?
Cash and short term investments quarterly total is $614.8M
What Is Cytokinetics’s Book Value Per Share?
Book value per share is -3.80

Is Cytokinetics Cash Flow Positive?

What Is CYTK Cash Flow From Operations?
Cash flow from operations (TTM) is -$414.3M
What Is Cytokinetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $221.3M
What Is Cytokinetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $239.3M

Cytokinetics Return On Invested Capital

Is Management Doing A Good Job?
CYTK return on invested capital is -168.42%
What Is Cytokinetics Return On Assets?
ROA measures how assets are converting to revenues and is -61.92%
What Is CYTK Return On Equity?
ROE is a measure of profitability and is 0%

Cytokinetics Earnings Date & Stock Price

What Is Cytokinetics's Stock Price Today?
A single share of CYTK can be purchased today for 67.55
What Is Cytokinetics’s Stock Symbol?
Cytokinetics trades on the nasdaq under the ticker symbol: CYTK
When Is Cytokinetics’s Next Earnings Date?
The next quarterly earnings date for Cytokinetics is scheduled on May 3, 2024
When Is CYTK's next ex-dividend date?
Cytokinetics's next ex-dividend date is April 20, 2024
How To Buy Cytokinetics Stock?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cytokinetics Competitors

Who Are Cytokinetics's Competitors?
Below is a list of companies who compete with Cytokinetics or are related in some way:
- Amgen Inc (AMGN)
- Johnson & Johnson (JNJ)
- Eli Lilly and Co (LLY)
- Madrigal Pharmaceuticals Inc (MDGL)
- Viking Therapeutics Inc (VKTX)

Cytokinetics Dividend Yield